SCHEMBL30042166

SCHEMBL30042166

Nc1c(C2CC2)ccc2c1CCC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
NOS3 P29474 1/20 0.36
NOS1 P29475 1/20 0.36
NOS2 P35228 1/20 0.36
BCL2L1 Q07817 1/20 0.34
BAD Q92934 1/20 0.34
IDO1 P14902 2/20 0.33
SIGMAR1 Q99720 2/20 0.33
NISCH Q9Y2I1 1/20 0.33
PARP1 P09874 1/20 0.33
TRPV1 Q8NER1 3/20 0.32
CYP17A1 P05093 1/20 0.32
CCNE2 O96020 1/20 0.31
CCNE1 P24864 1/20 0.31
CDK2 P24941 1/20 0.31
HTR1A P08908 1/20 0.31
HTR7 P34969 1/20 0.31
GRIN2D O15399 1/20 0.30
GRIN3B O60391 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25201444 1.00 HTR2C (0.36) HTR2CHTR2BNOS3NOS1NOS2
SCHEMBL23063367 0.88 NR1I2 (0.33) HTR2CHTR2BNOS3NOS1NOS2
SCHEMBL2049785 0.77 BCL2L1 (0.42) HTR2CHTR2BBCL2L1BADTRPV1
SCHEMBL18828495 0.76 HTR1A (0.50) HTR2CHTR2BBCL2L1BADIDO1
SCHEMBL21962348 0.74 UGT2B17 (0.32) NOS3NOS1NOS2GRIN1GRIN2A
SCHEMBL29574395 0.73
SCHEMBL21729545 0.73
SCHEMBL11779130 0.71 NOS3 (0.41) HTR2CNOS3NOS1NOS2BCL2L1
SCHEMBL20634317 0.69 NOS3 (0.39) HTR2CHTR2BNOS3NOS1NOS2
SCHEMBL25242966 0.69 HTR1D (0.43) HTR2CHTR2BNOS3NOS1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115461120-A Sulfonylimide compounds as NLRP3 modulators 豪夫迈·罗氏有限公司 2022-12-09 CN disclosed
EP-4093509-A1 SULFONIMIDAMIDE COMPOUNDS AS NLRP3 MODULATORS F. Hoffmann-La Roche AG (CH) 2022-11-30 EP disclosed